Works matching DE "RIVAROXABAN"

Results: 1504
    1
    2
    3
    4
    5
    6

    Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.

    Published in:
    Journal of Interventional Cardiac Electrophysiology, 2014, v. 41, n. 2, p. 107, doi. 10.1007/s10840-014-9924-9
    By:
    • Naccarelli, Gerald;
    • Cappato, Riccardo;
    • Hohnloser, Stefan;
    • Marchlinski, Francis;
    • Wilber, David;
    • Xiang, Jim;
    • Ma, Changsheng;
    • Hess, Susanne;
    • Davies, David;
    • Fields, Larry;
    • Natale, Andrea
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis—a prospective, stratified, randomized, controlled trial.

    Published in:
    International Orthopaedics, 2020, v. 44, n. 10, p. 2079, doi. 10.1007/s00264-020-04699-3
    By:
    • Zhang, Lu;
    • Li, Yanming;
    • Liu, Dong;
    • Xiao, Xing;
    • Guan, Tingjin;
    • Yue, Hongwei;
    • Xue, Haipeng;
    • Zhou, Hongming;
    • Jiao, Guangjun;
    • Wu, Wenliang;
    • Wang, Hongliang;
    • Liu, Haichun;
    • Meng, Chunyang;
    • Sun, Zhaozhong;
    • Chen, Yunzhen
    Publication type:
    Article
    16

    Treatment appropriateness of direct oral anticoagulants in patients with atrial fibrillation for stroke prevention: A real-world prospective study.

    Published in:
    European Journal of Clinical Pharmacology, 2025, v. 81, n. 1, p. 163, doi. 10.1007/s00228-024-03773-8
    By:
    • Pasebani, Yeganeh;
    • Rafati, Ali;
    • Dalouchi, Saied;
    • Bahadori, Mohammad Javad;
    • Ghoshouni, Hamed;
    • Haghjoo, Majid;
    • Fazelifar, Amir Farjam;
    • Alizadeh‐Diz, Abolfath;
    • Madadi, Shabnam;
    • Kamali, Farzad;
    • Hadavand, Naser;
    • Talasaz, Azita H;
    • Lip, Gregory Y. H.;
    • Emkanjoo, Zahra;
    • Sadeghipour, Parham
    Publication type:
    Article
    17

    Efficacy and safety of dabigatran and rivaroxaban in atrial fibrillation patients with impaired liver function: a multicenter retrospective cohort study.

    Published in:
    European Journal of Clinical Pharmacology, 2024, v. 80, n. 8, p. 1141, doi. 10.1007/s00228-024-03689-3
    By:
    • Huang, Xinhai;
    • Xu, Wenlin;
    • Wu, Guilan;
    • Li, Ruijuan;
    • Gu, Ping;
    • Zheng, Qiaowei;
    • Liu, Xiumei;
    • Dai, Hengfen;
    • Lin, Xiangsheng;
    • Liu, Yuxin;
    • Du, Xiaoming;
    • Su, Jun;
    • Zhang, Wang;
    • Zhang, Min;
    • Zhu, Zhu;
    • Huang, Xiaohong;
    • Huang, Nianxu;
    • Zhang, Jinhua
    Publication type:
    Article
    18
    19

    Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data.

    Published in:
    European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 797, doi. 10.1007/s00228-024-03648-y
    By:
    • Diesveld, Maaike M. E.;
    • Pijnenburg, Daniëlle W. M. Jacobs-;
    • Weersink, Rianne A.;
    • Barzel, Ina;
    • Drenth, Joost P. H.;
    • Lisman, Ton;
    • Metselaar, Herold J.;
    • Monster-Simons, Margje H.;
    • Mulder, Midas B.;
    • Okel, Eline;
    • Taxis, Katja;
    • Borgsteede, Sander D.
    Publication type:
    Article
    20
    21
    22

    Prevalence and bleeding risk associated with the concomitant use of direct oral anticoagulants and antiarrhythmic drugs in patients with atrial fibrillation, based on the French healthcare insurance database.

    Published in:
    European Journal of Clinical Pharmacology, 2023, v. 79, n. 7, p. 937, doi. 10.1007/s00228-023-03501-8
    By:
    • Gosselin, Laëtitia;
    • Vilcu, Ana-Maria;
    • Souty, Cécile;
    • Steichen, Olivier;
    • Launay, Titouan;
    • Conte, Cécile;
    • Saint-Salvi, Béatrice;
    • Turbelin, Clément;
    • Sarazin, Marianne;
    • Blanchon, Thierry;
    • Hanslik, Thomas;
    • Lapeyre-Mestre, Maryse;
    • Rossignol, Louise
    Publication type:
    Article
    23
    24
    25

    Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study.

    Published in:
    European Journal of Clinical Pharmacology, 2022, v. 78, n. 4, p. 557, doi. 10.1007/s00228-022-03280-8
    By:
    • Nosáľ, Vladimír;
    • Petrovičová, Andrea;
    • Škorňová, Ingrid;
    • Bolek, Tomáš;
    • Dluhá, Jana;
    • Stančiaková, Lucia;
    • Sivák, Štefan;
    • Babálová, Lucia;
    • Hajaš, Gabriel;
    • Staško, Ján;
    • Kubisz, Peter;
    • Kurča, Egon;
    • Samoš, Matej;
    • Mokáň, Marián
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Comparative risks of bleeding, ischemic stroke and mortality with direct oral anticoagulants versus phenprocoumon in patients with atrial fibrillation.

    Published in:
    European Journal of Clinical Pharmacology, 2018, v. 74, n. 10, p. 1317, doi. 10.1007/s00228-018-2504-7
    By:
    • Ujeyl, Mariam;
    • Köster, Ingrid;
    • Wille, Hans;
    • Stammschulte, Thomas;
    • Hein, Rebecca;
    • Harder, Sebastian;
    • Gundert-Remy, Ursula;
    • Bleek, Julian;
    • Ihle, Peter;
    • Schröder, Helmut;
    • Schillinger, Gerhard;
    • Zawinell, Anette;
    • Schubert, Ingrid
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    Rivaroxaban-induced hair loss.

    Published in:
    2015
    By:
    • Chrétien, Basile;
    • Besnard, Anne;
    • Sassier, Marion;
    • Le Hello, Claire;
    • Coquerel, Antoine;
    • Alexandre, Joachim;
    • Fedrizzi, Sophie
    Publication type:
    Letter
    45
    46
    47
    48
    49
    50